I just listened to the Noosa mining presentation. Was a bit shocked that it was delivered by Tessa but would like to think it was because SW had bigger fish to fry with potential partners. Although the presentation didn't go very deep into the detail and didn't even mention the stage we are at with the studies(ie impending DFS) it did mention two pearls. 1. The Woboden project concentrator could be restarted and be cashflow positive even at current Ni prices 2. Partner negotiations continue with Korean and Japanese entities and recently "a Vietnamese entity".
In terms of funding the purchase of Woboden the DFS will have to be compelling enough to convince a new equity partner and/or existing shareholders to step up to the plate once again.
Convincing us the purchase will lead to an ongoing revenue stream by the immediate restart of Woboden will be key. With 1.2mt of reserves the reduction in mine life ahead of the refinery construction will be inconsequential.
It may look dark right now but all is not lost imo.
GLTAH DYOR
- Forums
- ASX - By Stock
- BSX
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-82
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BSX (ASX) to my watchlist
|
|||||
Last
3.0¢ |
Change
0.001(3.45%) |
Mkt cap ! $15.79M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 3.0¢ | $9.97K | 332.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 29913 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 138929 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 29913 | 0.029 |
2 | 36998 | 0.027 |
1 | 37074 | 0.026 |
1 | 100000 | 0.020 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 138929 | 1 |
0.034 | 7901 | 1 |
0.035 | 124245 | 2 |
0.036 | 82192 | 1 |
0.037 | 125000 | 1 |
Last trade - 11.23am 13/08/2024 (20 minute delay) ? |
Featured News
BSX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online